Anti-GPRC5D/CD19 CAR T-cell therapy (Guangdong Second Provincial General Hospital)

N/A

Report date: 2025/06/11 10:30:49

Base Information

Drug NameAnti-GPRC5D/CD19 CAR T-cell therapy (Guangdong Second Provincial General Hospital)
Drug Alias Nameanti-GPRC5D-CD19 CAR-T cells infusion
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionG-protein coupled receptor family C group 5member D modulatorsT lymphocytes stimulantsImmunostimulants +[4] 
TargetsB-lymphocyte antigen CD19G-protein coupled receptor family C group 5member D
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe Second People Hospital Of Guangdong Province
China Registration ClassN/A

Develop Information

Active CompaniesThe Second People Hospital Of Guangdong Province
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A